EMG
NVAX icon

Ellington Management Group’s Novavax NVAX Stock Holding History

Ellington Management Group’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-15,000
Closed -$204K – 301
2020
Q1 		$204K Buy
+15,000
New +$127K 0.05% 433
2016
Q2 		– Sell
-1,180
Closed -$122K – 421
2016
Q1 		$122K Buy
+1,180
New +$127K 0.05% 456
2015
Q4 		– Sell
-1,976
Closed -$279K – 743
2015
Q3 		$279K Buy
+1,976
New +$443K 0.08% 445
2015
Q2 		– Sell
-690
Closed -$114K – 815
2015
Q1 		$114K Buy
+690
New +$112K 0.02% 636

Other funds holding NVAX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Ellington Management Group's NVAX Position: Q2 2020 in Review

Ellington Management Group sold out of Novavax (NVAX) in Q2 2020, closing a stake of 15,000 shares — an estimated $204K sold.

Ellington Management Group first reported a position in NVAX in Q1 2015 and held it in 4 quarters. The position peaked at $279K in Q3 2015. 213 funds tracked by Wall St. Rank hold NVAX as of Q2 2020.

  • Ellington Management Group reported no remaining Novavax position as of Q2 2020 after selling out during the quarter.
  • Ellington Management Group sold 15,000 Novavax shares in Q2 2020, an estimated $204K.
  • Ellington Management Group first reported a position in Novavax in Q1 2015 and held it in 4 quarters.
  • Ellington Management Group's Novavax position peaked at $279K in Q3 2015.
  • 213 funds tracked by Wall St. Rank held Novavax as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.